Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods

In this study, the minimal residual disease (MRD) levels in patients with multiple myeloma (MM) were assessed by comparing the new 8-color single-tube multiparameter flow cytometry method (DuraClone), which reduces the cost of antibodies and labor burden of laboratories, with the EuroFlow next-gener...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoroidaka, Takeshi, Narita, Kentaro, Takamatsu, Hiroyuki, Fujisawa, Momoko, Nakao, Shinji, Matsue, Kosei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160149/
https://www.ncbi.nlm.nih.gov/pubmed/34045494
http://dx.doi.org/10.1038/s41598-021-89761-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160149/
https://www.ncbi.nlm.nih.gov/pubmed/34045494
http://dx.doi.org/10.1038/s41598-021-89761-9

Ejemplares similares